Available to sourceHuman Prescription DrugOncology & Specialty

Ledipasvir and Sofosbuvir

90 mg/1 / 400 mg/1 · Film-Coated Tablet

By Asegua Therapeutics LLC

NDC: 72626-2601
Route: Oral
Therapeutic class: Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor , Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor , P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]
Marketing category: NDA AUTHORIZED GENERIC

Package sizes

2 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACKNDC 72626-2601-1Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Oncology & Specialty

See all →

Ledipasvir and Sofosbuvir

Package sizes

Additional information

Request this medication

Related in Oncology & Specialty

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)